| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.05 |